Company Registration No. 05480714 (England and Wales)
DAWAT PHARMA LIMITED
Unaudited accounts
for the year ended 31 March 2026
DAWAT PHARMA LIMITED
Unaudited accounts
Contents
DAWAT PHARMA LIMITED
Company Information
for the year ended 31 March 2026
Directors
Tanveer Ahmed
Usaamah Bin Ahmed
Company Number
05480714 (England and Wales)
Registered Office
103 Broadway West
Walsall
WS1 4DW
Accountants
Linktax Limited
11A Snow Hill
Stoke-on-Trent
Staffordshire
ST1 4LU
DAWAT PHARMA LIMITED
Statement of financial position
as at 31 March 2026
Tangible assets
5,974
7,028
Investments
125,000
125,000
Cash at bank and in hand
63,654
90,857
Creditors: amounts falling due within one year
(38,672)
(36,076)
Net current assets
24,982
54,964
Net assets
155,956
186,992
Called up share capital
1,000
1,000
Profit and loss account
154,956
185,992
Shareholders' funds
155,956
186,992
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 4 August 2026 and were signed on its behalf by
Tanveer Ahmed
Director
Company Registration No. 05480714
DAWAT PHARMA LIMITED
Notes to the Accounts
for the year ended 31 March 2026
DAWAT PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 05480714. The registered office is 103 Broadway West, Walsall, WS1 4DW.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% reducing balance method
4
Tangible fixed assets
Plant & machinery
DAWAT PHARMA LIMITED
Notes to the Accounts
for the year ended 31 March 2026
5
Investments
Other investments
Valuation at 1 April 2025
125,000
Valuation at 31 March 2026
125,000
Amounts falling due within one year
7
Creditors: amounts falling due within one year
2026
2025
Loans from directors
28,659
6,604
8
Average number of employees
During the year the average number of employees was 2 (2025: 6).